Shawn Zimberg, MD
Radiation Oncology · Plainview, NYNPI 1528021714
Payments from drug & device makers
Across 236 payments — averaging $2442.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioprotect Medical, Inc.$304K
- Bioprotect LTD.$130K
- Bayer$100K
- Novartis$22K
- Elekta, Inc.$11K
- Bayer Healthcare LLC$4K
- plus $4K from 21 others
What the payments were for
- Consulting fees$143,63135%
- Speaking & faculty fees$190,26246%
- Travel & lodging$69,29217%
- Food & beverage$7,6392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioprotect Medical, Inc. | 72 | $304,249 |
| Bioprotect LTD. | 6 | $130,050 |
| Bayer | 80 | $100,449 |
| Novartis | 14 | $21,642 |
| Elekta, Inc. | 2 | $11,302 |
| Bayer Healthcare LLC | 6 | $4,282 |
| Siemens Medical Solutions USA, Inc. | 12 | $1,783 |
| Johnson & Johnson | 3 | $1,135 |
| Varian Medical Systems, Inc. | 3 | $370 |
| Boston Scientific | 8 | $241 |
| Accord Healthcare, Inc. | 1 | $143 |
| Blue Earth Diagnostics | 4 | $88 |
| Myriad Genetic Laboratories, Inc. | 3 | $69 |
| Isoray, Inc | 4 | $67 |
| Tactile Systems Technology Inc | 3 | $61 |
| Coloplast | 1 | $59 |
| Myovant Sciences Inc. | 2 | $49 |
| Visionrt, Inc. | 1 | $47 |
| Bard Peripheral Vascular, Inc. | 2 | $44 |
| Zap Surgical Systems, Inc. | 1 | $41 |
| Dendreon Pharmaceuticals LLC | 1 | $37 |
| Lilly USA, LLC | 1 | $32 |
| Novocure Inc. | 2 | $30 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Fortovia Therapeutics, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOPROTECT BALLOON IMPLANT SYSTEM$287,779
- Xofigo$71,939
- PLUVICTO$19,464
- Nubeqa$7,351
- Erleada$1,010
- TrueBeam$222
- Varian Treatment$166
- Halcyon$148
- CAMCEVI$143
How this compares
$576,343 in reported general payments places this provider in the 95th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 19 | $134 |
| Methylprednisolone | 12 | $72 |
| Diazepam | 14 | $31 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Plainview
- Narek ShaverdianNew York$9.8M
- Timothy ChanNew York$3.8M
- Chung ChungSyracuse$3.1M
- Brandon ImberNew York$2.8M
- Silvia FormentiNew York$2.7M
- Steven FinkelsteinSyracuse$2.6M
- Christopher BarkerNew York$2.5M
- Chandan GuhaBronx$1.6M
- Michael ZelefskyNew York$1.5M
- Eileen ConnollyNew York$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.